Navigation Links
Study Confirms that OrbusNeich's Genous™ Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity
Date:7/11/2011

ate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, the Genous Stent, as well as other stents and balloons marketed under the names of Azule™, R stent, Scoreflex™, Sapphire™, Sapphire II and Sapphire NC. Development stage products include the Combo™ Bio-engineered Sirolimus Eluting Stent, or Combo Stent, which combines the Genous pro-healing technology for rapid endothelial coverage with an abluminal sirolimus drug elution for the control of neointimal proliferation. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich, which has provided medical devices to physicians through its predecessor companies since 1979, supplies products today to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.

Follow OrbusNeich on Twitter at www.twitter.com/OrbusNeich, and learn more about the company and the Genous technology on OrbusNeich's YouTube Channel: http://www.youtube.com/user/OrbusNeichMedical.


'/>"/>
SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Cardiologists at Henry Ford ... stroke in patients with an irregular heartbeat. With ... Henry Ford is able to add another option ... fibrillation, which affects the heart,s ability to pump. ... and first-ever commercial Watchman implant at a non-clinical trial ...
(Date:4/21/2015)... -- According to a new market ... Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), ... Contamination, Adventitious Agents) - Global Forecast to 2019", ... Market was valued at $1,758.69 Million in 2014. ... CAGR of 12.23% to reach $3,130.85 Million in ...
(Date:4/21/2015)... -- Seattle Children,s announced today that 20 of 22 ... genetically reprogrammed T cells to treat relapsed acute lymphoblastic ... sensitive tests designed to detect minute amounts of cancer ... included children with very high tumor burdens as well ... "These results are extremely encouraging," said ...
Breaking Medicine Technology:Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 2Biologics Safety Testing Market Worth $3,130.85 Million by 2019 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 4Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 2Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 3
(Date:4/21/2015)... 2015 Dr. Aaron Choroomi, dentist in ... are now offering a valuable discount on restorative dental implants. ... promotional price of only $1695 for a limited time. This ... for a limited time. , "There are times that ... the price," dental implants dentist , Dr. Choroomi, stated. ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Zane Benefits, ... businesses, announced today the publication of a new guide ... reform brought changes to the health insurance industry, including ... business owners to question what is permitted when implementing ... small business owners determine which HRAs are compliant this ...
(Date:4/21/2015)... 2015 Le Petit Retreat Day Spa in ... today in the leafy, historic Larchmont neighborhood, newly renamed as ... new theme of “Disconnect to Reconnect.” Tina Figueroa, a ... award-winning day spa, announces the new name and new vision ... offerings that help celebrate connections with Moms and their adult ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Zane Benefits, ... announced today its CEO Rick Lindquist has been selected ... 2015. , According to Rick Lindquist, “There is a ... and Zane Benefits’ small business solutions are at its ... provided by Employee Benefit Adviser’s Rising Stars.” , According ...
(Date:4/21/2015)... April 21, 2015 Carinsurancesavings.biz has released a ... under proper surveillance and explaining the impact on a ... vehicles safe and supervised may be eligible for advantageous auto ... in a simple and efficient way. This will also help ... convenient and simple way. , Finding low cost coverage is ...
Breaking Medicine News(10 mins):Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2
... in Reducing Infections for Patients in Intensive Care , ... in southeast Pennsylvania have successfully reduced or eliminated healthcare-associated ... and are featured in the Pennsylvania Patient Safety Authority,s ... Patients in intensive care are at high risk for ...
... to Vaccinate 1.2 Million Americans - , , ... Caremark,s retail clinic division, have received the National Influenza ... Campaign. The award, co-sponsored by the American Medical ... was presented yesterday evening in Dallas as health care ...
... Physicians Association (RPA) supports Kidney Care Partners (KCP) recently ... initiative. RPA is a member of KCP, a coalition ... and nurses who work together to improve quality care ... PEAK campaign is to reduce first-year dialysis patient mortality ...
... ... estimated 15-20 million American women, sex hurts. Most suffer in silence because they ... stinging, or stabbing pain in the genital area, urinary urgency, irritable bowel, low ... or enjoying, sex. For the first time, a new book brings this taboo ...
... Amsterdam, The Netherlands: Women with cystic fibrosis can have ... long-term adverse effects on either themselves or their children, ... meeting of the European Society of Human Reproduction and ... cystic fibrosis (CF) was a death sentence and most ...
... have a diminished number of eggs in their ovaries, either ... as ovarian surgery, may be more at risk of a ... normal, fertile range. Trisomic pregnancies occur when the embryo ... two. The most common trisomy is Down,s syndrome or trisomy ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Releases June Advisory 2Health News:Pennsylvania Patient Safety Authority Releases June Advisory 3Health News:Pennsylvania Patient Safety Authority Releases June Advisory 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 5Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 2Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 2Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 4Health News:Women with cystic fibrosis can have safe and successful fertility treatment 2Health News:Women with cystic fibrosis can have safe and successful fertility treatment 3Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... The PRO6000 power supply is ... power supply product offering. It ... and genomic electrophoresis. This product ... proteomic applications such as microAmp ...
... Operating as a constant voltage power supply, the ... knob and hilo range switch control the output, ... to 250 volts. One, two-position switch toggles the ... output current. The 105 is equipped with an ...
... The 250-90 low voltage electrophoresis power supply ... 500 milliamps and 125 watts. This product operates ... continuously variable output. The 250-90 automatically crosses over ... when a preset limit is reached. ...
Medicine Products: